Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idraparinux for thromboembolism prevention in atrial fibrillation
NCT00070655Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2003
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of idraparinux in thromboembolism, stroke, sponsored by Sanofi. Started Sep 2003; status: completed.
02
Drugs
idraparinux
03
Conditions
thromboembolismstroke
Beyond the preview
Go deeper on NCT00070655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070655.